Immunome, Inc.

Immunome, Inc. is a clinical-stage targeted oncology company dedicated to developing innovative therapies for cancer patients. They focus on creating first- and best-in-class targeted therapies, with a particular emphasis on antibody-drug conjugate therapies (ADCs). Their pipeline includes AL102, a gamma secretase inhibitor currently in a Phase 3 trial for desmoid tumors, as well as IM-1021, a ROR1 ADC, and IM-3050, a FAP-targeted radioligand, both of which are expected to enter clinical trials soon.

Immunome is committed to pursuing underexplored targets and employing appropriate drug modalities to create transformative therapies. They utilize their proprietary memory B cell hybridoma technology to rapidly screen and functionally characterize novel antibodies and targets. The company is headquartered in Bothell, Washington, and is actively expanding its portfolio through both internal discovery efforts and strategic business development initiatives.

Immunome, Inc. is an Equal Employment Opportunity employer committed to creating a diverse and inclusive work environment. They do not discriminate based on race, religion, color, national origin, gender, sexual orientation, gender identity, gender expression, age, veteran status, or disability status. For employees with disabilities who need reasonable accommodations, they can contact HR@immunome.com or call 1-610-321-3700.

Immunome is a clinical-stage targeted oncology company focused on developing first-in-class and best-in-class therapies for cancer patients. They are committed to pursuing underexplored targets with appropriate drug modalities, including small molecules, ADCs, RLTs and immunotherapies, to create transformative therapies that improve outcomes for patients with unmet medical needs.

Immunome fosters a collaborative and diverse work environment that values outstanding scientific and business talent. The company promotes a culture where employees feel empowered to do their best work, contributing to the development of effective antibody-based therapeutics for unmet medical needs.

Immunome, Inc. is committed to fostering a diverse and inclusive workplace where all employees feel empowered to do their best work. They strive to create an environment where all employees feel respected and valued, regardless of their race, religion, color, national origin, gender, sexual orientation, gender identity, gender expression, age, veteran status, disability status, or other protected characteristics. Immunome provides reasonable accommodations to individuals with disabilities who need assistance accessing their materials and information.